Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: A randomized, double-blind, non-inferiority study

Clinical Drug Investigation

Volumn 32, Issue 6, 2012, Pages 387-399

  Scholtz, Arne Wulf ^a   Steindl, Raluca ^a   Burchardi, Nicole ^b   Bognar Steinberg, Irene ^b   Baumann, Wolfgang ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b Medical Department   (Germany)

Author keywords

betahistine; cinnarizinedimenhydrinate; ear disorders; vertigo; vestibular disorder therapies

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIVERTIGO AGENT; ARLEVERT; BETAHISTINE; CINNARIZINE PLUS DIMENHYDRINATE; THYROMIMETIC AGENT; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BODY EQUILIBRIUM; CALORIC VESTIBULAR TEST; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; ELECTRONYSTAGMOGRAPHY; FEMALE; HUMAN; HYPERTENSION; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; NYSTAGMUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REMISSION; STABILOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE; VERTIGO; VESTIBULAR NEURONITIS; VESTIBULAR TEST; VISUAL ANALOG SCALE;

ADULT; BETAHISTINE; CINNARIZINE; DIMENHYDRINATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ELECTRONYSTAGMOGRAPHY; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VESTIBULAR NEURONITIS;

EID: 84861066218     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/11632410-000000000-00000     Document Type: Article

References (48)

1. Magnusson M, Karlberg M. Peripheral vestibular disorders with acute onset of vertigo. Curr Opinion Neurol 2002; 15: 5-10
2. Baloh RW. Vestibular neuritis. N Engl J Med 2003; 348: 1027-32
3. Hain TC, Uddin M. Pharmacological treatment of vertigo. CNS Drugs 2003; 17: 85-100
4. Salvinelli F, Firrisi M, Casale M, et al. What is vertigo? Clin Ter 2003; 154: 341-8
5. Curthoys IS, Halmagyi GM. Vestibular compensation: A review of the oculomotor, neural, and clinical consequences of unilateral vestibular loss. J Vest Res 1995; 5: 67-107
6. Darlington CL, Smith PF. Molecular mechanisms of recovery from vestibular damage in mammals: recent advances. Progress Neurobiol 2000; 62: 313-25
7. Fishman JM, Burgess C, Waddell A. Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis). Cochrane Database Syst Rev 2011; 5. CD008607. DOI: 10.1002/14651858.CD008607.pub2
8. HalmagyiGM, Weber KP, Curthoys IS. Vestibular function after acute vestibular neuritis. Rest Neurol Neurosci 2010; 28: 33-42
9. Shupak A, Issa A, Golz A, et al. Prednisone treatment for vestibular neuritis. Otol Neurotol 2008; 29: 368-74
10. Walker MF. Treatment of vestibular neuritis. Curr Treat Options Neurol 2009; 11: 41-5
11. Hain TC, Yacovino D. Pharmacologic treatment of persons with dizziness. Neurol Clin 2005; 23: 831-53
12. Schremmer D, Bognar-Steinberg I, Baumann W, et al. Efficacy and tolerability of a fixed combination of cinnarizine and dimenhydrinate in treatment of vertigo: Analysis of data from five randomised, double-blind clinical studies. Clin Drug Invest 1999; 18: 355-68
13. Pytel J, Nagy G, Tóth A, et al. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: A 4-week, randomized, double-blind, active- and placebo-controlled, parallel group, outpatient study. Clin Ther 2007; 29: 84-98
14. Cirek Z, Schwarz M, Baumann W, et al. Efficacy and tolerability of a fixed combination of cinnarizine and dimenhydrinate versus betahistine in the treatment of otogenic vertigo. A double-blind, randomised clinical study. Clin Drug Invest 2005; 25: 377-89
15. Hahn A, Sejna I, Stefflova B, et al. A fixed combination of cinnarizine/dimenhydrinate for the treatment of patients with acute vertigo due to vestibular disorders: A randomized, reference-controlled clinical study. Clin Drug Invest 2008; 28: 89-99
16. Scholtz AW, Schwarz M, Baumann W, et al. Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: A doubleblind, randomized, parallel-group clinical study. Clin Ther 2004; 26: 866-77
17. Mira E. Improving the quality of life in patients with vestibular disorders: the role of medical treatments and physical rehabilitation. Int J Clin Pract 2008; 62: 109-14
18. Jeck-Thole S, Wagner W. Betahistine: A retrospective synopsis of safety data. Drug Safety 2006; 29: 1049-59
19. Lacour M, van de Heyning PH, Novotný M, et al. Betahistine in the treatment of Ménière's disease. Neuropsych Dis Treatment 2007; 3: 429-40
20. Redon C, Lopez C, Bernard-Demanze L, et al. Betahistine treatment improves the recovery of static symptoms in patients with unilateral vestibular loss. J Clin Pharmacol 2011; 51: 538-48
21. Nasher LM, Peters J. Dynamic posturography in the diagnosis and management of dizziness and balance disorders. Neurol Clin 1990; 8: 331-49
22. Newman S, Lambert PR. Neuro-ophthalmic manifestations of neurotologic disease. In: Jackler RK, Brackmann DE, editors. Neurotology. 2nd ed. Philadelphia (PA): Elsevier Mosby; 2005: 228-40
23. Jongkees LB, Maas JP, Philipszoon AJ. Clinical nystagmography: A detailed study of electronystagmography in 341 patients with vertigo. Practical Oto-Rhino-Laryngol 1962; 24: 65-93
24. Committee for Proprietary Medicinal Products (CPMP). Points to consider on switching between superiority and non-inferiority. CPMP/EWP/482/99. London: 2000 July
25. Novotný M, Kostrica R. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: A randomized, double-blind, parallelgroup clinical study. Int Tinnitus J 2002; 8: 115-23
26. Novotný M, Bognar-Steinberg I, Baumann W. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Méniè re's disease: post hoc non-inferiority analysis of a prospective, randomized, double-blind study. Arch Sensol Neurotol-ASN 2011; 6 [online]. Available from URL: Http://neurotology. org. ISSN 1612-3352 [Accessed 2011 August 12]
27. Scholtz A-W. Therapieoptionen bei Neuropathia vestibularis. In: Iro H, Waldfahrer F, editors. Vertigo-Kontroverses und Bewährtes. 8. Hennig Symposium. Wien: Springer, 2011: 169-74
28. Godfraind T, Towse G, van Nueten JM. Cinnarizine: A selective calcium entry blocker. Drugs Today 1982; 18: 27-42
29. Soto E, Vega R. Neuropharmacology of vestibular system disorders. Curr Neuropharmacol 2010; 8: 26-40
30. Arab SF, Duewel P, Juengling E, et al. Inhibition of voltagegated calcium currents in type II vestibular hair cells by cinnarizine. Naunyn-Schmied Arch Pharmacol 2004; 369: 570-5
31. Haasler T, Homann G, Duong Dinh TA, et al. Pharmacological modulation of transmitter release by inhibition of pressure-dependent potassium currents in vestibular hair cells. Naunyn-Schmied Arch Pharmacol 2009; 380: 531-8
32. Jaju BP, Wang SC. Effects of diphenhydramine and dimenhydrinate on vestibular neuronal activity of cat: A search for the locus of their antimotion sickness action. J Pharmacol Exp Ther 1971; 176: 718-24
33. Mateijsen DJM, Hengel PWJ, Kingma H, et al. Vertigo and electronystagmography in uni- and bilateral Méniè re's disease. ORL 2001; 63: 341-8
34. Honrubia V, Jenkins HA, Minser K, et al. Vestibulo-ocular reflexes in peripheral labyrinthine lesions: II. Caloric testing. Am J Otolryngol 1984; 5: 93-8
35. Shupak A, Gordon CR, Nachum Z. The role of vestibular testing in the evaluation of patients engaged in occupations in non-Terrestrial conditions. Otorhinolaryngol Nova 2001; 11: 105-17
36. Steindl R, Kunz K, Schrott-Fischer A, et al. Effect of age and sex on maturation of sensory systems and balance control. Dev Med Child Neurol 2006; 48: 477-82
37. Cevette MJ, Puetz B, Marion MS, et al. A physiologic performance on dynamic posturography. Otolaryngol Head Neck Surg 1995; 112: 676-88
38. Peppard SB. Effect of drug therapy on compensation from vestibular injury. Laryngoscope 1986; 96: 878-98
39. Piratello AC, Mattioli R. Effects of chlorpheniramine and L-histidine on vestibular compensation in goldfish, Carassius auratus. Neurosci Lett 2004; 367: 160-3
40. Tolu E, Mameli O, Caria MA, et al. Improvement of vestibular plasticity in the guinea pig with a calcium entry blocker. Acta Otolaryngol 1988; 460 (Suppl.): 72-9
41. Schneider D, KieXling B, Wieczorek M, et al. Influence of antivertiginous medications on the vigilance of healthy volunteers. Int J Clin Pharmacol Ther 2003; 41: 171-81
42. Philipova D, Tzenova B, Iwanowitsch A, et al. Influence of an antivertiginous combination preparation of cinnarizine and dimenhydrinate on event-related potentials, reaction time and psychomotor performance: A randomized, doubleblind, 3-way crossover study in healthy volunteers. Int J Clin Pharmacol Ther 2004; 42: 218-31
43. Goebel JA. The ten-minute examination of the dizzy patient. Seminars Neurol 2001; 21: 391-8
44. Luxon LM. A bit dizzy. Br J Hosp Med December 1984: 315-22
45. Vanspauwen R, Weerts A, Hendrickx M, et al. No effects of anti-motion sickness drugs on vestibular evoked myogenic potentials outcome parameters. Otol Neurotol 2011; 32: 497-503
46. Palla A, Straumann D, Bronstein AM. Vestibular neuritis: vertigo and the high-Acceleration vestibule-ocular reflex. J Neurol 2008; 255: 1479-82
47. Ariyasu L, Byl FM, Sprague MS, et al. The beneficial effect of methylprednisolone in acute vestibular vertigo. Arch Otolaryngol Head Neck Surg 1990; 116: 700-3
48. Kitahara T, Kondoh K, Morihana T, et al. Steroid effects on vestibular compensation in humans. Neurol Res 2003; 25: 287-91